Garry Arthur Neil insider trades
Open-market stock purchases and sales by Garry Arthur Neil, Unknown at Celldex Therapeutics, Inc, from SEC Form 4 filings since Sep 13, 2013.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +275%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc | Bought (not open market) | — |
| May 21, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
| Mar 28, 2026 | AVTX Avalo Therapeutics, Inc | Sold (not open market) | $304K |
| Mar 28, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CLDX Celldex Therapeutics, Inc: other filings, last Jun 25, 2026
- AVTX Avalo Therapeutics, Inc: 3 buys, last May 21, 2026
- ZURA Zura Bio Ltd: other filings, last May 18, 2023
- ARNA Arena Pharmaceuticals Inc: other filings, last Mar 11, 2022
- CERC Cerecor Inc: 3 buys, last Jun 10, 2021
- GNMX Aevi Genomic Medicine, Inc: 3 buys, last Feb 3, 2020
- GTXI GTX Inc /de/: other filings, last Oct 1, 2018
- MDGN Medgenics, Inc: 2 buys, last Apr 15, 2016